Brief: Elisabeth Svanberg Appointed As Chairman Of Pharnext Board Of Directors
23/12/2021 07:31
Dec 23 (Reuters) - Pharnext SA PHARN.PA :
* EXPERIENCED PHARMACEUTICAL INDUSTRY EXECUTIVE DR.
ELISABETH
SVANBERG APPOINTED AS CHAIRMAN OF PHARNEXT BOARD OF DIRECTORS
* ELISABETH SVANBERG TO SUCCEED MICHEL DE ROSEN AS CHAIRMAN
OF
BOARD OF DIRECTORS EFFECTIVE JANUARY 1ST, 2022
* MICHEL DE ROSEN HAS SERVED AS CHAIRMAN OF BOARD SINCE JUNE
2016
AND WILL CONTINUE TO SERVE AS A NON-EXECUTIVE DIRECTOR
Source text for Eikon: ID:nEQ6YYGw3a
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development